Indometacin Mcc

Indometacin, the active ingredient in Indometacin Mcc, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as a suppository for rectal use. It treats pain and inflammation associated with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gouty arthritis and other inflammatory conditions.

GNH USA supplies Indometacin Mcc as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indometacin is employed in the management of inflammatory musculoskeletal disorders and acute gout attacks. - Rheumatoid arthritis: reduces joint pain, swelling and stiffness. - Osteoarthritis: alleviates chronic joint discomfort and improves mobility. - Ankylosing spondylitis: diminishes spinal inflammation and pain. - Acute gouty arthritis: relieves sudden joint swelling and severe pain. - General pain and inflammation: provides symptomatic relief in various acute inflammatory conditions.

Indometacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal discomfort or nausea. - Headache or dizziness. - Skin rash or mild itching. - Mild abdominal pain.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Acute renal impairment or failure. - Severe liver injury or hepatitis.

Indometacin should be used with caution and under medical supervision. - Renal function: monitor in patients with existing kidney disease. - Gastrointestinal risk: avoid in individuals with a history of ulcer or bleeding. - Cardiovascular health: use cautiously in patients with heart disease or hypertension. - Concomitant anticoagulants: increased risk of bleeding; monitor coagulation parameters. - Pregnancy and lactation: safety not established; avoid if possible. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Indometacin can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - Lithium: increased lithium serum concentrations. - Methotrexate: amplified toxicity and bone‑marrow suppression.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may exacerbate renal impairment. - Corticosteroids: increased likelihood of gastrointestinal ulceration.